Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'
Kimberly-Clark CEO Mike Hsu discussed his company's $48.7 billion acquisition of Kenvue in a Monday interview with CNBC's Jim Cramer.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Kenvue
since
auto-detected in 17 stories
33 days ago
Kimberly-Clark to buy Tylenol maker Kenvue for $40bn
The deal has analysts puzzled, as the US maker of Tylenol has seen sales dip after the White House linked it to autism.
Stocks making the biggest moves midday: Amazon, Adeia, Kenvue, Iren & more
These are the stocks posting the largest moves midday.
34 days ago
Stocks making the biggest moves premarket: Iren, Kenvue, Cipher Mining, New Gold and more
These are some of the stocks posting the largest moves in premarket trading.
Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant ⊕
The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol.
Kimberly-Clark swoops on Kenvue in $49bn deal
Takeover will combine ownership of brands including Kleenex and Band-Aid
Kimberly-Clark to buy Kenvue in $48.7 billion deal ⊕
Kenvue's shareholders will receive $3.50 per share and 0.15 Kimberly-Clark shares for each Kenvue share held.
75 days ago
Stocks making the biggest moves premarket: Firefly Aerospace, AutoZone, Kenvue & more
These are the stocks posting the largest moves in early trading.
Kenvue shares fall on reports Trump will link its Tylenol painkiller to autism
found
a story from Financial Times ✅ › Financial Times
President Donald Trump due to make announcement about medical findings relating to American children’s health
Stocks making the biggest moves midday: Oracle, Apple, Metsera, Compass, Kenvue and more
See which stocks are posting big moves in midday trading.